MyFinsight
Home
Blog
About
Back
Income Statement
Monte Rosa Therapeutics, Inc. (GLUE)
Monte Rosa Therapeutics, Inc. (GLUE)
source: myfinsight.com
Comprehensive (loss) income
-$43,816K
(-255.10%↓ Y/Y)
Provision for pension
benefit obligation
-$54K
(-201.89%↓ Y/Y)
Net (loss) income
-$43,397K
(-252.96%↓ Y/Y)
Unrealized loss on
available-for-sale securities
$473K
(387.63%↑ Y/Y)
Interest income
$5,916K
(92.83%↑ Y/Y)
Foreign currency
exchange loss
$25K
(-98.20%↓ Y/Y)
Net (loss) income
before income taxes
-$43,189K
(-289.23%↓ Y/Y)
Income tax provision
$208K
(-82.65%↓ Y/Y)
Total other income
$5,941K
(33.27%↑ Y/Y)
(loss) income from
operations
-$49,130K
(-215.87%↓ Y/Y)
Collaboration revenue
$8,968K
(-61.33%↓ Y/Y)
Total operating
expenses
$58,098K
(49.94%↑ Y/Y)
Research and development
$47,964K
(56.47%↑ Y/Y)
General and
administrative
$10,134K
(25.19%↑ Y/Y)
Back